Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3BCHECHRM1CHRM2CHRM3CHRM4CHRNA3CHRNA4CHRNB2CHRNB4ESR1ESR2GABRA1GABRB1GABRG2GBA1GHSRHRH1HTR1DHTR2AMAOBOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8UGCGrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | CA4 | P22748 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL11588906 | 1.00 | TSHR (0.44) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL843543 | 0.96 | TSHR (0.47) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL31542424 | 0.96 | TSHR (0.47) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL157370 | 0.96 | TSHR (0.47) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL191752 | 0.92 | LMNA (0.48) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL6227892 | 0.92 | TSHR (0.44) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL9620390 | 0.92 | TSHR (0.44) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL5961174 | 0.92 | LMNA (0.48) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL11878569 | 0.92 | TSHR (0.44) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL330144 | 0.92 | TSHR (0.44) | TSHRLMNACA4CYP3A4TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7875571-B2 | Molybdenum, vanadium, tellurium, niobium, and palladium mixed oxide modified with a metal oxide precursor of niobium, molybdenum, vanadium, tungsten, zirconium, tantalum, or bismuth and then calcined; oxidizing alkanes to unsaturated carboxylic acids | ROHM AND HAAS COMPANY (US) | 2011-01-25 | — | — | US | disclosed |
| EP-1908518-A1 | Mixed metal oxide catalysator doped with one of Mo, Nb, V, W, Zr, Ta or Bi | Rohm and Haas Company (US) | 2008-04-09 | — | — | EP | disclosed |
| US-20080064590-A1 | Activated mixed metal oxide oxidation catalysts | ROHM AND HAAS COMPANY | 2008-03-13 | — | — | US | disclosed |